FDA Clears KORU FreedomEDGE for RYSTIGGO Infusion
MAHWAH, N.J., January 29, 2026 — KORU Medical Systems has received U.S. FDA 510(k) clearance expanding the labeled use...
AI drug discovery AI healthcare artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
MAHWAH, N.J., January 29, 2026 — KORU Medical Systems has received U.S. FDA 510(k) clearance expanding the labeled use...
UNITED STATES | January 27, 2026 — ABANZA, a medical technology company focused on advancing soft-tissue fixation solutions, announced...
CORONADO, CALIFORNIA | January 26, 2026 — Spine Innovation, LLC announced it has received FDA 510(k) clearance to market...
